Skip to main content

38 Result(s)

within D. Kup**er Remove this filter Laboratory Medicine Remove this filter

previous disabled Page of 2
and

  1. No Access

    Article

    Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello, Anat Loewenstein… in Eye (2024)

  2. No Access

    Article

    Aflibercept biosimilars – update on the development progress

    Ashish Sharma, Anat Loewenstein, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello… in Eye (2024)

  3. No Access

    Article

    Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?

    Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, Nilesh Kumar, Alok Rasal… in Eye (2024)

  4. No Access

    Article

    Biosimilar ranibizumab interchangeability: what does it mean to retinal physicians?

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Carl Regillo, Francesco Bandello… in Eye (2023)

  5. No Access

    Article

    Approved biosimilar ranibizumab—a global update

    Ashish Sharma, Mineo Kondo, Chiharu Iwahashi, Nikulaa Parachuri, Nilesh Kumar… in Eye (2023)

  6. No Access

    Article

    Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity

    Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello… in Eye (2023)

  7. No Access

    Article

    Fear of safety compromise with biosimilar anti-VEGF—perception or truth

    Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello… in Eye (2022)

  8. No Access

    Article

    Retina: a unique subspecialty in the biosimilar landscape

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Francesco Bandello… in Eye (2022)

  9. No Access

    Article

    Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study)

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello… in Eye (2022)

  10. No Access

    Article

    On label bevacizumab for retina: where it stands

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Anat Loewenstein, Francesco Bandello… in Eye (2022)

  11. Article

    Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Dhatri Karanam, Baruch D. Kuppermann… in Eye (2022)

    Download PDF (355 KB) View Article

  12. No Access

    Article

    The Port Delivery System with ranibizumab—journey of mitigating vitreous hemorrhage

    Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Baruch D. Kuppermann… in Eye (2022)

  13. No Access

    Article

    Semaglutide and the risk of diabetic retinopathy—current perspective

    Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Bharat Saboo, Hridaya Nath Tripathi… in Eye (2022)

  14. No Access

    Article

    Vortex vein anastomosis and pachychoroid—an evolving understanding

    Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello… in Eye (2021)

  15. No Access

    Article

    Brolucizumab—foreseeable workflow in the current scenario

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Baruch D. Kuppermann… in Eye (2021)

  16. No Access

    Article

    Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Sonali Singh, Francesco Bandello… in Eye (2021)

  17. Article

    Correction: Comment on: ‘Recent advances in anterior chamber angle imaging’

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Nilesh Kumar, Francesco Bandello, Baruch D. Kuppermann, Ashish Sharma in Eye (2020)

    Download PDF (275 KB) View Article

  18. No Access

    Article

    Comment on: ‘Recent advances in anterior chamber angle imaging’

    Nilesh Kumar, Francesco Bandello, Baruch D Kuppermann, Ashish Sharma in Eye (2020)

  19. No Access

    Article

    Brolucizumab and immunogenicity

    Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Rohini Sharma, Francesco Bandello… in Eye (2020)

  20. No Access

    Article

    Brolucizumab—another anti-VEGF or beyond

    Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Rohini Sharma, Francesco Bandello… in Eye (2020)

previous disabled Page of 2